Anterior Cingulate Cortex Pyramidal Neurons

Introduction

Anterior Cingulate Cortex Pyramidal Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The anterior cingulate cortex (ACC) is a key region in the medial prefrontal cortex, critically involved in cognitive control, emotion regulation, and pain processing. Its pyramidal neurons form the primary excitatory population. ^{1"Anterior cingulate in neurodegenerative disease." *Brain*2023 · Brain}

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: pyramidal neuron (source: Cell Ontology)

  • Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000598)

• OBO Foundry (CL:0000598)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000598)

• OBO Foundry (CL:0000598)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Morphology and Markers

ACC pyramidal neurons have distinctive features:

• Large pyramidal cell bodies with extensive dendritic arbors

• Vglut1-positive: Express vesicular glutamate transporter 1

• Layer-specific markers: Layer 2/3 (Cux1), Layer 5 (CTIP2/Bcl11b), Layer 6 (Tbr1)

• Long-range projections: Subcortical and callosal projection neurons

• Intrinsic properties: Regular spiking and intrinsic bursting subtypes

Normal Function

Cognitive and Emotional Processing

The ACC is a hub for cognition and emotion:

1. Cognitive control: ACC monitors conflict and guides behavioral adjustment

2. Pain processing: ACC encodes the affective dimension of pain

3. Emotion regulation: ACC regulates emotional responses

4. Reward anticipation: ACC tracks expected rewards and outcomes

Key Functions

• Error detection: ACC responds to errors and conflict

• Decision making: ACC integrates information for value-based decisions

• Social cognition: ACC processes social exclusion and empathy

• Motor control: ACC plans and executes voluntary movements

• Pain affect: ACC generates the emotional suffering component of pain

Circuitry

ACC Pyramidal Neurons → (glutamate) → ACC Local Circuits
ACC Layer 5 → (glutamate) → Striatum, Thalamus, Brainstem
ACC Layer 2/3 → (glutamate) → Other Cortical Areas
ACC → (callosal) → Contralateral ACC

Disease Vulnerability

Alzheimer’s Disease

• Early dysfunction: ACC shows hypometabolism in early AD (MCI)

• Cognitive decline: ACC atrophy correlates with executive dysfunction

• Mood symptoms: Depression in AD involves ACC dysfunction

• Reference: ACC hypometabolism predicts progression from MCI to AD^[1]

Parkinson’s Disease

• Cognitive impairment: ACC dysfunction contributes to PD-MCI

• Depression: Altered ACC activity in PD depression

• Pain: ACC encodes pain in PD patients with pain symptoms

• Reference: ACC functional connectivity changes in PD^[2]

Frontotemporal Dementia

• Early involvement: ACC is affected in behavioral variant FTD

• Disinhibition: Loss of ACC control contributes to FTD symptoms

• Emotional processing: Altered emotional recognition in FTD

Other Conditions

• Depression: ACC hyperactivity in major depressive disorder

• Schizophrenia: Reduced ACC activity during cognitive tasks

• Chronic pain: ACC sensitization in chronic pain states

• PTSD: ACC dysfunction in trauma and anxiety disorders

Transcriptomic Profile

• Excitatory neurons: Express SLC17A7 (Vglut1)

• Layer-specific: Different transcriptomic profiles across layers

• Projection neurons: Distinct types for different projection targets

• Interneurons: Local inhibitory circuits modulate pyramidal neurons

Therapeutic Implications

Deep Brain Stimulation

• ACC has been explored for depression and chronic pain

• May help with cognitive dysfunction in neurodegenerative disease

Pharmacological Targets

• Glutamate receptors: NMDA and AMPA modulators

• Serotonergic drugs: SSRIs affect ACC function

• Pain drugs: Targeting ACC for analgesic development

Biomarkers

• ACC activity measured by fMRI as a biomarker

• ACC thickness on MRI as a neurodegenerative marker

• Functional connectivity between ACC and other regions

• Dorsolateral Prefrontal Cortex

• Medial Prefrontal Cortex

• Orbitofrontal Cortex

• Infralimbic Cortex

• Alzheimer’s Disease

• Parkinson’s Disease

• Frontotemporal Dementia

• Pain in Neurodegeneration

Background

The study of Anterior Cingulate Cortex Pyramidal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Pathway Diagram

graph TD
    ASTROCYTES["ASTROCYTES"] -->|"associated with"| CORTEX["CORTEX"]
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"associated with"| CORTEX["CORTEX"]
    NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| CORTEX["CORTEX"]
    APOPTOSIS["APOPTOSIS"] -->|"associated with"| CORTEX["CORTEX"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| CORTEX["CORTEX"]
    NF_KB["NF-KB"] -->|"associated with"| CORTEX["CORTEX"]
    TNF["TNF"] -->|"associated with"| CORTEX["CORTEX"]
    NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| CORTEX["CORTEX"]
    TARDBP["TARDBP"] -->|"associated with"| CORTEX["CORTEX"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated with"| CORTEX["CORTEX"]
    AMYLOID["AMYLOID"] -->|"associated with"| CORTEX["CORTEX"]
    APP["APP"] -->|"associated with"| CORTEX["CORTEX"]
    style ASTROCYTES fill:#1b4d1e,stroke:#333,color:#e0e0e0
    style CORTEX fill:#006494,stroke:#333,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#ef5350,stroke:#333,color:#e0e0e0
    style NEUROINFLAMMATION fill:#5d4400,stroke:#333,color:#e0e0e0
    style APOPTOSIS fill:#5d4400,stroke:#333,color:#e0e0e0
    style MICROGLIA fill:#1b4d1e,stroke:#333,color:#e0e0e0
    style NF_KB fill:#006494,stroke:#333,color:#e0e0e0
    style TNF fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURODEGENERATION fill:#5d4400,stroke:#333,color:#e0e0e0
    style TARDBP fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#ef5350,stroke:#333,color:#e0e0e0
    style AMYLOID fill:#006494,stroke:#333,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#333,color:#e0e0e0